Savior Lifetec Corporation (TPEX:4167)

Taiwan · Delayed Price · Currency is TWD

19.40

-0.30 (-1.52%)

Sep 24, 2026, 1:30 PM CST

Market Cap	6.43B +13.5%
Revenue (ttm)	1.12B -7.2%
Net Income	1.03B +124.9%
EPS	3.10 +129.6%
Shares Out	331.55M
PE Ratio	6.26
Forward PE	n/a
Dividend	0.75 (3.88%)
Ex-Dividend Date	Jul 28, 2026

Volume	604,041
Open	19.65
Previous Close	19.70
Day's Range	19.30 - 19.70
52-Week Range	15.40 - 21.20
Beta	0.13
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About Savior Lifetec

Savior Lifetec Corporation engages in the research, development, design, manufacture, and sale of carbapenem generics in the Americas, Asia, Taiwan, Europe, and internationally. The company offers injection generics, controlled-release generics, the development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms. It also provides medicine manufacturer technology and services. In addition, the company sells antibacterial raw materials and injectables. Savior Lifetec Corporation was founded in 1993 and is head... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1993

Employees 384

Stock Exchange Taipei Exchange

Ticker Symbol 4167

Full Company Profile

Financial Performance

In 2025, Savior Lifetec's revenue was 1.20 billion, a decrease of -1.28% compared to the previous year's 1.22 billion. Earnings were 537.45 million, an increase of 194.69%.

Financial Statements